CClinicalTrials.gg
CompletedNCT01251510Updated Jan 23, 2013

Bile Acid-induced GLP-secretion. A Study in Cholecystectomized Subjects

An observational study in Diabetes, sponsored by University Hospital, Gentofte, Copenhagen. Completed at 1 site in Denmark. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-01-23.

Sponsored by University Hospital, Gentofte, Copenhagen · Observational

Study type
Observational
Enrollment
20
Ages
18 Years to 70 Years
Sex
All
01

Study summary

PURPOSE

The goal of the present project is to unravel the importance of bile acid-induced GLP-1 secretion (via the G protein-coupled receptor TGR5) in human physiology.

In the present study the investigators examine the GLP-1 secretion in healthy subjects and cholecystectomised patients. Thereby the investigators aim to show, that cholecystectomised patients have reduced bileflow after a meal, and as a consequence exhibit a diminished GLP-1 response as compared to healthy subjects.

02

Conditions studied

  • Diabetes
03

In context

Lead sponsor

University Hospital, Gentofte, Copenhagen is the lead sponsor of 154 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy subjects and cholcystectomised patients (chol)

Eligibility criteria

Inclusion Criteria: (Healthy)

  • Normal fasting plasma glucose
  • Normal glucose tolerance
  • Normal haemoglobin levels
  • Informed content

Inclusion Criteria: (cholecystectomy group)

  • Laparoscopic cholecystectomy \<6 months. Indication: Gallstones.
  • Normal fasting plasma glucose
  • Normal glucose tolerance
  • Normal haemoglobin levels
  • Informed content

Exclusion Criteria: (both groups)

  • Diabetes
  • Pre diabetes (impaired glucose tolerance or impaired fasting glucose)
  • 1st degree relatives with diabetes
  • Obesity (BMI > 30)
  • Inflammatory bowels disease
  • Nephropathy
  • Liver disease
  • Medication which cannot be on hold for 24h
05

Study design

Enrollment
20 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Healthy adults
  • Type 2 diabetes
06

What researchers measure

Primary outcomes

  1. GLP-1 secretion

    Time frame: Postprandial

07

Study locations

1 site
  • Gentofte University Hospital
    Hellerup, 2900, Denmark
08

References and documents

Publications

  • Sonne DP, Hare KJ, Martens P, Rehfeld JF, Holst JJ, Vilsboll T, Knop FK. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G413-9. doi: 10.1152/ajpgi.00435.2012. Epub 2012 Dec 28. PubMed 23275610 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01251510
Lead sponsor
University Hospital, Gentofte, Copenhagen
Responsible party
David P. Sonne (MD, University Hospital, Gentofte, Copenhagen) — Principal investigator
First posted
Dec 2, 2010
Start date
Oct 2010
Primary completion
Jun 2011
Completion
Jun 2011
Last update
Jan 23, 2013

Study contacts

David P. Sonne, MD
principal investigator · Gentofte Hospital, University of Copenhagen

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion